Suppr超能文献

非小细胞肺癌微环境中CD8 FOXP3 T细胞、CD8 T细胞和FOXP3 T细胞的浸润情况。

Infiltration of CD8 FOXP3 T cells, CD8 T cells, and FOXP3 T cells in non-small cell lung cancer microenvironment.

作者信息

Hao Jianqing, Wang Helin, Song Lai, Li Shuping, Che Nanying, Zhang Shucai, Zhang Hongtao, Wang Jinghui

机构信息

Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing, China.

Department of Oncology, First Affiliated Hospital of Xinxiang Medical University Xinxiang, Henan, China.

出版信息

Int J Clin Exp Pathol. 2020 May 1;13(5):880-888. eCollection 2020.

Abstract

BACKGROUND

Studies about CD8 FOXP3 T cells as a subtype of regulatory T cells (Treg cells) in non-small cell lung cancer (NSCLC) are few. Associations among the clinicopathologic factors of NSCLC and tumor-infiltrating lymphocytes (TILs) such as CD8 FOXP3 T cells, CD8 T cells, FOXP3 T cells and tumor PD-L1 expression are unclear.

METHODS

We retrospectively enrolled 192 patients who underwent resections for NSCLC. We used tissue microarrays (TMA) with multiplex immunofluorescence and immunohistochemistry staining to evaluate the expression of CD8, FOXP3, cytokeratin, DAPI and PD-L1. We then used Wilcoxon test, Kaplan-Meier method, and Cox hazard proportion model to analyze their relationships with clinicopathologic factors and prognosis.

RESULTS

Density of tumor CD8 FOXP3 T cells was significant by univariate analysis, and positively associated with tumor CD8 T cells and FOXP3 T cells. Density of tumor CD8 T cells was higher in lung adenocarcinoma (LUAD) than squamous cell carcinoma (LUSC), and was an independent prognostic factor for NSCLC. The density of tumor FOXP3 T cells decreased with tumor size. Tumor PD-L1 expression was higher in LUSC than LUAD. Cox hazard proportion model analysis correlated being younger than 65 years, early TNM stage, early T stage, high tumor CD8 T cell density, and adjuvant chemotherapy with longer overall survival.

CONCLUSION

Infiltration of CD8 FOXP3 T cells, CD8 T cells, and FOXP3 T cells is important in non-small cell lung cancer microenvironment, and needs to be investigated more.

摘要

背景

关于CD8 FOXP3 T细胞作为非小细胞肺癌(NSCLC)中调节性T细胞(Treg细胞)亚型的研究较少。NSCLC的临床病理因素与肿瘤浸润淋巴细胞(TILs)如CD8 FOXP3 T细胞、CD8 T细胞、FOXP3 T细胞以及肿瘤PD-L1表达之间的关联尚不清楚。

方法

我们回顾性纳入了192例行NSCLC切除术的患者。我们使用组织微阵列(TMA)进行多重免疫荧光和免疫组织化学染色,以评估CD8、FOXP3、细胞角蛋白、DAPI和PD-L1的表达。然后我们使用Wilcoxon检验、Kaplan-Meier方法和Cox风险比例模型来分析它们与临床病理因素及预后的关系。

结果

单因素分析显示肿瘤CD8 FOXP3 T细胞密度具有显著性,且与肿瘤CD8 T细胞和FOXP3 T细胞呈正相关。肺腺癌(LUAD)中肿瘤CD8 T细胞密度高于肺鳞癌(LUSC),并且是NSCLC的独立预后因素。肿瘤FOXP3 T细胞密度随肿瘤大小增加而降低。LUSC中肿瘤PD-L1表达高于LUAD。Cox风险比例模型分析显示,年龄小于65岁、早期TNM分期、早期T分期、高肿瘤CD8 T细胞密度以及辅助化疗与更长的总生存期相关。

结论

CD8 FOXP3 T细胞、CD8 T细胞和FOXP3 T细胞的浸润在非小细胞肺癌微环境中具有重要意义,需要进一步研究。

相似文献

2
Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer.
J Thorac Dis. 2020 May;12(5):1824-1842. doi: 10.21037/jtd-19-3414a.
4
[CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):254-264. doi: 10.3779/j.issn.1009-3419.2021.103.05.
5
Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.
Oncotarget. 2016 Sep 27;7(39):64318-64329. doi: 10.18632/oncotarget.11793.
7
Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
Oral Oncol. 2020 Mar;102:104560. doi: 10.1016/j.oraloncology.2019.104560. Epub 2020 Jan 7.

引用本文的文献

4
Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis.
Front Immunol. 2024 Sep 20;15:1476365. doi: 10.3389/fimmu.2024.1476365. eCollection 2024.
6
FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma.
Acta Biochim Biophys Sin (Shanghai). 2024 May 26;56(7):1011-1021. doi: 10.3724/abbs.2024082.
7
Tumor microenvironment characteristics and prognostic role of mA modification in lung squamous cell carcinoma.
Heliyon. 2024 Feb 28;10(5):e26851. doi: 10.1016/j.heliyon.2024.e26851. eCollection 2024 Mar 15.
8
A bioinformatic analysis of the role of TP53 status on the infiltration of CD8+ T cells into the tumor microenvironment.
Braz J Med Biol Res. 2023 Oct 20;56:e12970. doi: 10.1590/1414-431X2023e12970. eCollection 2023.
9
AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3.
Hum Vaccin Immunother. 2023 Dec 15;19(3):2269790. doi: 10.1080/21645515.2023.2269790. Epub 2023 Oct 25.
10
ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis.
Medicine (Baltimore). 2023 Sep 8;102(36):e35013. doi: 10.1097/MD.0000000000035013.

本文引用的文献

1
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
N Engl J Med. 2019 Nov 21;381(21):2020-2031. doi: 10.1056/NEJMoa1910231. Epub 2019 Sep 28.
4
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
N Engl J Med. 2018 Nov 22;379(21):2040-2051. doi: 10.1056/NEJMoa1810865. Epub 2018 Sep 25.
5
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4.
7
Advances on CD8+ Treg Cells and Their Potential in Transplantation.
Transplantation. 2018 Sep;102(9):1467-1478. doi: 10.1097/TP.0000000000002258.
8
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.
9
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
10
Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer.
Oncotarget. 2017 Aug 12;8(48):83986-83994. doi: 10.18632/oncotarget.20233. eCollection 2017 Oct 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验